| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |